In a study of US dialysis patients with diabetes published Oct. 27, 2026, in Diabetes Care, semaglutide users had a 1-year death rate of 11% vs. 13% with dulaglutide or liraglutide, and fewer hospitalizations, though the benefit vs. liraglutide alone…
In a study of 61 people with kidney failure, published Oct. 8, 2026, in Frontiers in Immunology, a two-step pneumococcal vaccine schedule produced a global antibody response in 73.6% of dialysis patients at 12 months vs. 39.3% of transplant recipients.
A study of 103 people on hemodialysis, published Oct. 22, 2026, in BMC Nephrology, found that 17.5% lost physical performance over about 18.6 months, and lower hip bone density and longer time on dialysis were linked to decline.
A Cochrane review published Oct. 26, 2026, pooled 27 randomized trials with 1,584 people on hemodialysis. Music-based interventions may reduce fatigue, depressive symptoms and pain in the short term, but the certainty of the evidence is low.